Navigation Links
West Penn Allegheny Health System Physicians Pinpoint Gastroesophageal Reflux Disease (GERD) as a Factor That May Cause Chronic Cough
Date:5/24/2013

Pittsburgh, PA (PRWEB) May 24, 2013

Patients who have chronic cough with no known cause may be more likely to suffer from gastroesophageal reflux disease or GERD, West Penn Allegheny Health System physicians reported in a study published today.

The article, “Antireflux Surgery in Patients with Chronic Cough and Abnormal Proximal Exposure as Measured by Hypopharyngeal Multichannel Intraluminal Impedance” appears in JAMA Surgery.

“These findings could be of great importance to individuals who live with a nagging cough without a known cause,” said Blair A. Jobe, MD, principal investigator of the study and Director of the Institute for the Treatment of Esophageal and Thoracic Disease at West Penn Allegheny Health System.

“Undergoing screening and, if applicable, treatment for GERD can not only improve patients’ quality of life by curbing chronic cough, it can also help prevent serious conditions such as Barrett’s esophagus and esophageal cancer.”

GERD occurs when the muscles at the end of the esophagus fail to properly close, allowing stomach contents to leak back or reflux into the esophagus, causing irritation. Common symptoms of GERD include heartburn, regurgitation, and tasting stomach acid in the back of the throat. Hoarseness, a feeling of having a “lump in your throat” and frequent throat clearing are lesser known symptoms of GERD.

The trial examined 314 patients who underwent testing with a specialized catheter to detect reflux and determined that 49 of them also had chronic cough, a persistent cough with no known cause lasting more than eight weeks. Of the patients with chronic cough, 52 percent were diagnosed with GERD.

“These patients did not display classic symptoms of GERD and may not have been diagnosed with conventional pH testing which measures the amount of stomach acid in the esophagus,” said Toshitaka Hoppo, MD, a general surgeon specializing in esophageal surgery who was involved in the trial.

For such patients, undergoing Hypopharyngeal Multichannel Intraluminal Impedance (HMII) testing is key to achieving a diagnosis. HMII is ideal for assessing the proximity of reflux events from the lower esophageal sphincter muscle regardless of their pH level.

Of the 49 patients with chronic cough in the study, 73 percent were found to have abnormal proximal exposure of reflux. Sixteen of those patients underwent antireflux surgery with 81 percent achieving resolution of their cough.

“Once GERD is diagnosed, many patients may benefit from antireflux surgery,” Dr. Jobe said. “The increased sensitivity of HMII testing enables us to properly diagnose patients who don’t display the telltale signs and symptoms of GERD, treat the underlying problem and prevent future complications while relieving their cough.”

Chronic cough is a condition that affects 8 to 12 percent of adults.

The Institute for the Treatment of Esophageal and Thoracic Disease at WPAHS is a comprehensive, multi-disciplinary program that focuses on the treatment of patients with lung cancer, mediastinal diseases, esophageal cancer, Barrett’s esophagus, hiatal hernia, esophageal motility disorders, gastroesophageal reflux disease, and swallowing issues.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10764784.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. West Penn Allegheny Health System is First in Pennsylvania to Perform Groundbreaking Minimally-Invasive Procedure for Swallowing Disorder
2. Study by Allegheny General Hospital Physicians Shows Oral Immunotherapy is a Safe, Effective Alternative to Allergy Shots for Ragweed Sufferers
3. 2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning
4. Scott Tischler of Tischler Brothers Fitness Unveils the 7 Rules to a Healthy Diet
5. Dermasis Psoriasis Treatment Cream for Men and Women Released Online at HealthCareSupplementz.com
6. Susquehanna Health Offers Safe Sitter Course for Tweens and Teens
7. Netsmart Named to Healthcare Informatics Top 100 List
8. PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release
9. Health2Go Announces Research That DHEA Helps Depression
10. DUXIANA®, Quality Bed Innovator, Celebrates Better Sleep Month and Launches Summer Health Campaign
11. Healthcare Internet Marketing Consulting Services Launched by JD Media Surge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... agreement to be the preferred physical therapy provider for Derby City CrossFit, effective ... Derby City CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent ... test score performance for the 2015-16 school year across Wisconsin’s public schools, charter ... it highlights important patterns in student test score performance, the report’s limited analyses ...
(Date:4/25/2017)... ... April 25, 2017 , ... As ... contracted partners to help with process innovation in drug formulation and manufacturing. ... along with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
Breaking Medicine Technology: